Detecting intratumoral heterogeneity of EGFR activity by liposome-based in vivo transfection of a fluorescent biosensor

Despite decades of research in the epidermal growth factor receptor (EGFR) signalling field, and many targeted anti-cancer drugs that have been tested clinically, the success rate for these agents in the clinic is low, particularly in terms of the improvement of overall survival. Intratumoral hetero...

Descripción completa

Detalles Bibliográficos
Autores principales: Weitsman, G, Mitchell, N J, Evans, R, Cheung, A, Kalber, T L, Bofinger, R, Fruhwirth, G O, Keppler, M, Wright, Z V F, Barber, P R, Gordon, P, de Koning, T, Wulaningsih, W, Sander, K, Vojnovic, B, Ameer-Beg, S, Lythgoe, M, Arnold, J N, Årstad, E, Festy, F, Hailes, H C, Tabor, A B, Ng, T
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5421598/
https://www.ncbi.nlm.nih.gov/pubmed/28166195
http://dx.doi.org/10.1038/onc.2016.522

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5421598/
https://www.ncbi.nlm.nih.gov/pubmed/28166195
http://dx.doi.org/10.1038/onc.2016.522

Ejemplares similares